DOCSLIB.ORG

A Guide to Prescription Drug Pricing in New York

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Guide to Prescription Drug Pricing in New York A GUIDE TO PRESCRIPTION DRUG PRICING IN NEW BUYER BEWARE ORK Y NEW YORK PUBLIC INTEREST RESEARCH GROUP SEPTEMBER 2018 Acknowledgements Written by Blair Horner with Megan Ahearn, Kevin Dugan and Russ Haven of NYPIRG. © 2018, NYPIRG Fund To receive a copy of this report, visit our website and download the report at: www.nypirg.org NYPIRG 107 Washington Avenue Albany, N.Y. 12210 BUYER BEWARE A REVIEW OF PRECRIPTION DRUGS PRICES IN NEW YORK STATE Summary of Findings his Guide documents the price differences for the six most widely available brand name T drugs found in the New York State Department of Health’s database.1 We reviewed the top six most frequently prescribed medicines for the purposes of this Guide. Consumers can use the New York Department of Health website to check any one of the top 150 most prescribed drugs to shop for the lowest cost, https://apps.health.ny.gov/pdpw/SearchDrugs/Home.action. The prices are updated weekly.2 Finding: There were huge price differences by region. Our review shows surprisingly large ranges in the retail prices of drugs within geographic regions. In the city of Albany, the drug Advair Diskus had the greatest range in price, from a high of $417.97 to a low of $263.99 – a difference of $153.98. In the city of Binghamton, the drug Advair Diskus had the greatest range in price, from a high of $417.97 to a low of $277.94 – a difference of $140.03. In the city of Buffalo, Ventolin HFA Inhaler had the greatest range in price, from a high of $177.17 to a low of $44.59 – a difference of $132.58. In the city of Ithaca, the drug Nexium had the greatest range in price, from a high of $292.99 to a low of $201.32 – a difference of $91.67. In the city of Rochester, the drug Advair Diskus had the greatest range in price, from a high of $389.99 to a low of $230.99 – a difference of $159. In the city of Syracuse, the drug Nexium had the greatest range in price, from a high of $348.97 to a low of $188.99 – a difference of $159.98. In suburban counties surrounding New York City we examined three communities. In Suffolk County, in Commack the drug with the greatest range in price – Nexium, from a high of $304.99 to a low of $188.43 – a difference of $116.56. In Nassau County, in Hempstead the drug with the greatest range in price was Advair Diskus, from a high of $379.29 to a low of $225 – a difference of $154.29. In Westchester County, in White Plains the drug with the greatest range in price was Advair Diskus, from a high of $411.50 to a low of $253.32 – a difference of $158.18. Within New York City we examined areas contained in or near zip codes in each borough. (a) In one area in the Bronx the drug with the greatest range in price was Advair Diskus, from a high of $350.50 to a low of $267.39 – a difference of $83.11. (b) In one area in Brooklyn the drug with the greatest range in price was Advair Diskus, from a high of $346.49 to a low of $230.99 – a difference of $115.50. (c) In one area in Manhattan the drug with the greatest range in price was Advair Diskus, from a high of $467.75 to a low of $260 – a difference of $207.75. (d) In one area in Queens the drug with the greatest range in price was Lantus Solostar, from a high of $188.05 to a low of $123.72 – a difference of $64.33. (e) In one area in Staten Island the drug with the greatest range in price was Advair Diskus, from a high of $396.19 to a low of $283.99 – a difference of $112.20. These price differences within the regions of New York underscore the financial threat posed to residents who lack prescription drug coverage. For those individuals, checking the state’s website can save a bundle. But that can only work if they know of the website’s existence. Finding: Many pharmacies appear to fail to display the drug price website address, as required by law. NYPIRG conducted a spot check of pharmacies across New York State, including in the regions of Albany, Buffalo, Manhattan, Nassau, Queens, Rochester, and Syracuse, to test whether consumers could easily find the required website posting as required under state law. We found 12 of 29 pharmacies that had signs displaying the state’s drug price website. In addition, when the web address was observed, it was difficult to understand the value of the site and the URL itself was difficult to remember. Recommendations hile the intent of New York State’s drug pricing disclosure law is laudable, it is clear from W our review that the law needs improvements. 1. The New York State Department of Education should audit pharmacies in order to ensure that they are complying with regulations requiring that pharmacies conspicuously display information on the existence of the New York State Department of Health website and its Internet address. The current law requires that pharmacies alert consumers to the existence of the state’s prescription drug price website address. However, we have found that of the pharmacies we visited, many don’t appear to display the required sign, leaving many consumers unaware of its existence. Internet posting of comparative prescription drug pricing information can help consumers save money quickly and easily. 2. The New York State Department of Education should require clear signage so that consumers can easily understand the benefits of the website. At the locations that did post the web address of the price comparison website, it was listed with the sign “Retail Drug Price Available” and did little to educate consumers on the value of comparison shopping. 3. The New York State Department of Health should review its database to identify pharmacies that appear to be charging unusually high retail prices. While there are many reasons why there would be a range in prices, some of the prices we observed were exceedingly high. Moreover, pharmacy and supermarket chains often have significant price differences for the same products, the justification of which should be investigated as well. Lastly, some of the prices we observed contained oddly specific charges. 4. The New York State Department of Health should change the URL address of the drug pricing website. While clearer signage would help consumers, having an easy-to- remember website address would as well. For example, www.NYSRxPriceShop.gov. BUYER BEWARE 2 Background n 2005, a state law was enacted that promised to substantially improve the way New Yorkers I could comparison shop for their prescription drugs. Prior to enactment, the only way consumers could find good value – particularly those consumers without any drug coverage – was to request pricing information directly from pharmacies. Pharmacies were required to give consumers this information for 150 of the most often prescribed drugs, if requested. To compare prices, a consumer would have to travel from pharmacy to pharmacy. The law, which went into effect in 2006, required the New York State Department of Health to create a website that would allow consumers to easily compare prescription prices. Under the new law, the Department would cull the pricing information from a database it already maintained through the state’s Medicaid program. At that time, supporters were told that retail pricing information comparable in scope to that previously available directly from pharmacies would now be available to consumers through “one-stop” online shopping. In order to examine the price differences in each region of the state, the New York Public Interest Research Group (NYPIRG) searched the most current pricing information contained in the Department’s database as available on the state’s website. In addition, we “spot checked” pharmacies’ compliance with the requirement to publicize the website address. Of course, for many New Yorkers this information is not very useful. If an individual has coverage through an employer plan or a government plan, the cost of a prescription is a relatively small co-pay. However, for those without health insurance, inadequate health insurance, or seniors facing the “doughnut hole” in the Medicare Part D coverage,3 price comparisons matter. The number of New Yorkers who could benefit from this program is large. For example, according to the U.S. Census, in 2016 nearly 1.2 million New York residents lacked health insurance.4 This “spot check” price check and review of compliance raises serious concerns about the program. Despite its existence for over a decade, wide price variations continue and pharmacies appear to ignore the requirement that the web address for the state’s pricing website be posted at or near the checkout counter. Without that notice, New Yorkers simply cannot benefit from the price comparison law. This Guide explains how the website works and compares prices in targeted regions across the state. We hope the information is helpful to New Yorkers who need the information. Moreover, we urge the New York State Education Department’s Board of Pharmacy to immediately review whether the anecdotal violations of the disclosure requirement are, in fact, widespread across the state. BUYER BEWARE 3 Range of High to Low in Prescription Drug Prices by Region he price differences within the regions of New York underscore the need for stronger T compliance with the state price disclosure law and point to the need for a stronger law.
Load more

Recommended publications
  • Overview of Ftc Antitrust Actions in Pharmaceutical Services and Products
    OVERVIEW OF FTC ANTITRUST ACTIONS IN PHARMACEUTICAL SERVICES AND PRODUCTS Health Care Division Bureau of Competition Federal Trade Commission Washington D.C. 20580 Markus H. Meier Assistant Director Bradley S. Albert Deputy Assistant Director Saralisa C. Brau Deputy Assistant Director September 2009 TABLE OF CONTENTS Page I. INTRODUCTION. ........................................................... 1 II. CONDUCT INVOLVING PHARMACEUTICAL SERVICES AND PRODUCTS. 3 A. Monopolization. ...................................................... 3 B. Agreements Not to Compete. ............................................ 8 C. Agreements on Price or Price-Related Terms. 14 D. Agreements to Obstruct Innovative Forms of Health Care Delivery or Financing. 20 E. Illegal Tying and Other Arrangements. .................................... 20 III. PHARMACEUTICAL MERGERS. ........................................... 20 A. Horizontal Mergers Between Direct Competitors. 20 B. Potential Competition Mergers. ......................................... 44 C. Innovation Market Mergers. ............................................ 47 D. Vertical Mergers...................................................... 49 IV. INDUSTRY GUIDANCE STATEMENTS...................................... 50 A. Advisory Opinions. ................................................... 50 B. Citizen Petition to the Food and Drug Administration. 51 V. AMICUS BRIEFS. ......................................................... 51 VI. INDICES. ............................................................
    [Show full text]
  • Youth Access Tobacco Enforcement Program Annual Report 04-05
    Youth Access Tobacco Enforcement Program Annual Report October 1, 2004 - September 30, 2005 � TobaccoSales To Youth New York State Department of Health Questions or requests for additional copies of this report: New York State Department of Health Bureau of Community Environmental Health & Food Protection Tobacco Enforcement Program Flanigan Square, Room 515 547 River Street Troy, NY 12180-2216 Telephone: (518) 402-7600 or 1 (800) 458-1158, ext. 27600 Fax: (518) 402-7609 This annual report of the New York State Department of Health (NYS DOH) Youth Access Tobacco Enforcement Program is prepared in accordance with Section 1399-kk of the Public Health law and is submitted by the Commissioner of Health to the Governor and the Legislature. ACKNOWLEDGEMENTS Special thanks go to the local health department enforcement officers, the New York City Department of Consumer Affairs and the youth who participated in the access compliance check surveillance initiative. Staff of the New York State Department of Health’s Bureau of Community Environmental Health and Food Protection Tobacco Enforcement Program prepared this report with data provided from the local enforcement officers, other State agencies and programs within the Department of Health. The New York State Department of Health’s Tobacco Control Program and the New York State Education Department supplied information regarding tobacco use and trends among minors. The State Department of Taxation and Finance provided registration and revenue data. The Department of State’s Office of Fire Prevention
    [Show full text]
  • PRECEDENTIAL UNITED STATES COURT of APPEALS for the THIRD CIRCUIT ___Nos. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-46
    Case: 14-4203 Document: 003112598145 Page: 1 Date Filed: 04/19/2017 PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ______ Nos. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-4602 & 14-4632 ______ IN RE: LIPITOR ANTITRUST LITIGATION Rite Aid Corporation; Rite Aid Hdqtrs. Corporation; JC (PJC) USA, LLC; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd Corporation, Appellants in No. 14-4202 Walgreen Company; The Kroger Co.; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company L.P., Appellants in No. 14-4203 Giant Eagle, Inc., Appellant in No. 14-4204 Meijer, Inc.; Meijer Distribution, Inc., Appellants in No. 14-4205 Rochester Drug Co-Operative, Inc.; Stephen L. LaFrance Pharmacy, Inc. d/b/a SAJ Distributors; Burlington Drug Company, Inc.; Value Drug Company; Professional Drug Company, Inc.; American Sales Company LLC, Appellants in No. 14-4206 Case: 14-4203 Document: 003112598145 Page: 2 Date Filed: 04/19/2017 A.F.L.-A.G.C. Building Trades Welfare Plan; Mayor and City Council of Baltimore, Maryland; New Mexico United Food and Commercial Workers Union’s and Employers’ Health and Welfare Trust Fund; Louisiana Health Service Indemnity Company, d/b/a Blue Cross/Blue Shield of Louisiana; Bakers Local 433 Health Fund; Twin Cities Bakery Workers Health and Welfare Fund; Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund; International Brotherhood of Electrical Workers Local 98; New York Hotel Trades Counsel & Hotel Association of New York City, Inc., Health Benefits Fund; Edward Czarnecki; Emilie Heinle; Frank Palter; Andrew Livezey; Edward Ellenson; Jean Ellyne Dougan; Nancy Billington, on behalf of themselves and all others similarly situated, Appellants in No.
    [Show full text]
  • CVS Corporation 2004 Annual Report H Cvrs Narrative 3/17/05 12:18 PM Page +6
    h_cvrs_narrative 3/17/05 12:17 PM Page +3 At CVS, it’s all in a day’s work... CVS Corporation 2004 Annual Report h_cvrs_narrative 3/17/05 12:18 PM Page +6 2:00am Another customer finds relief. From a toddler’s ear infection to a flare up of asthma, illnesses often have little regard for the clock. CVS has been doing its part to help, with approximately 60 percent of our stores offering 24- or extended- hour service. It’s just one of the many ways we make our pharmacy experience “CVS easy.”™ After all, the pharmacy accounts for 70 percent of our overall sales. CVS has a 13.5 percent share of the retail pharmacy market nationally, and we fill one in every five prescriptions in markets where we operate. Thanks to the Pharmacy Service Initiative (PSI) we launched in 2003, CVS is also making sure that prescriptions are “ready when promised”™ at any hour. Our pharmacy initiatives have freed up our pharmacists to spend more time counseling customers as well. As a result, customer service scores posted healthy gains in 2004. To realize similar benefits in the acquired Eckerd stores, we completed the training of more than 11,000 pharmacists and pharmacy support personnel on CVS systems, service processes, and standards. With more than 5,300 retail stores throughout the country and more on the way, CVS is well positioned to benefit from long-term pharmacy growth trends. The U.S. population is aging, healthcare costs are rising, and pharmaceuticals remain often the most cost-effective form of treatment.
    [Show full text]
  • Long Island University Arnold & Marie Schwartz College of Pharmacy And
    Long Island University Arnold & Marie Schwartz College of Pharmacy and Health Sciences 1998-2000 Undergraduate & Graduate Bulletin Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University 75 DeKalb Avenue, Brooklyn, NY 11201-5497 General Information: (718) 488-1000 http://www.liu.edu Admissions: (718) 488-1011 Fax: (718) 797-2399 Email: [email protected] The Arnold & Marie Schwartz College of Pharmacy and Health Sciences Undergraduate & Graduate Bulletin is issued biennially. A schedule of classes is published by the Office of the Registrar for the Fall, Spring and Summer sessions. Notice to Students. Long Island University reserves the right to delete any course described in this publication for any reason and cannot guarantee enrollment into any specific sections of courses. The University also reserves the right to effect any other changes in the curriculum, administration, tuition and fees, program offerings, or any other phase of school activity without notice. The University expects each student to have a knowledge of the information presented in the bulletin and other official publications of the various faculties and campuses pertaining to his/her course of study. For further information or specific degree requirements, prospective students should call the Admissions Office and enrolled students should speak with their advisers. College of Pharmacy and Health Sciences College of Pharmacy and Health Sciences; the Friends LONG ISLAND UNIVERSITY World Program of global education for social change; var - sity and intramural teams in 76 sports; WPBX-FM and WCWP-FM, Long Island’s Public Radio Network; the Long Island University, the United States’ eighth- world-renowned Tilles Center for the Performing Arts; largest private university measured by enrollment, is a and a proud, accomplished group of more than 135,000 multi-campus, doctoral degree-granting institution serving alumni and alumnae.
    [Show full text]
  • Petitoner's Jurisdictional Brief
    IN THE FLORIDA SUPREME COURT S. Ct. Case No.: CASE NO.: 3D05-2253 GARRETT DENT, Petitioner/Plaintiff, vs. DENNIS PHARMACY, INC., Respondent/Defendant. __________________________/ PETITONER’S JURISDICTIONAL BRIEF Respectfully submitted, David S. Wieder, Esq. Fla. Bar No.:153129 David S. Wieder, P.A. Hermelee & Geffin, LLC Counsel for Garrett Dent 25 S.E. 2nd Ave., Suite 1135 Miami, Florida 33131 Telephone: (305) 373-5444 Facsimile: (305) 373-0039 & David Hagen, Esq. Fla. Bar No.: 158143 49 E. Flagler St., PH104 Miami, Florida 33131 Telephone:(305) 373-4200 Facsimile: (305) 403-4900 TABLE OF CONTENTS TABLE OF CONTENTS ii TABLE OF AUTHORITIES iii OTHER AUTHORITIES iv STATEMENT OF THE CASE AND FACTS 1 STATEMENT OF JURISDICTION 2 SUMMARY OF THE ARGUMENT 3 ARGUMENT 4 THE DISTRICT COURTS ARE IN DIRECT CONFLICT REGARDING WHETHER A PHARMACIST HAS A DUTY TO WARN CUSTOMERS OF DANGERS ASSOCIATED WITH A PRESCRIPTION DRUG. 4 THE DISTRICT COURTS ARE IN DIRECT CONFLICT REGARDING WHETHER RELIANCE IS A NECESSARY ELEMENT OF A VOLUNTARY UNDERTAKING CAUSE OF ACTION. 7 THE DISTRICT COURTS ARE IN DIRECT CONFLICT REGARDING WHETHER AN UNIDENTIFIED THIRD PARTY CAN FALL WITHIN A REASONABLE AND FORESEEABLE ZONE OF RISK. 8 THE THIRD DISTRICT COURT EXPRESSLY DECLARED VALID FLA. STAT. §465.003 AND FLA. ADMIN. CODE R. 64B16-27.820. 10 CONCLUSION 10 CERTIFICATE OF TYPE SIZE AND STYLE 11 CERTIFICATE OF SERVICE 12 ii TABLE OF AUTHORITIES Arab Termite and Pest Control v. Jenkins, 409 So. 2d 1039 (Fla. 1982). 2 Cheeks v. Dorsey, 846 So. 2d 1169 (Fla. 4th DCA 2003). 9 Clay Electric v.
    [Show full text]
  • United States Securities and Exchange Commission Washington, D.C
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended February 29, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission File Number 1-5742 RITE AID CORPORATION (Exact name of registrant as specified in its charter) Delaware 23-1614034 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 30 Hunter Lane, Camp Hill, Pennsylvania 17011 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (717) 761-2633 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $1.00 par value RAD New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to section 13 or section 15(d) of the Exchange Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Revised January 21, 2016
    RITE AID CORPORATION DISTRIBUTION CENTERS / SHIP–TO-LOCATIONS ENTITY REFERENCE DC SHIP-TO-LOCATIONS / PO DEA NUMBER DUNS NO.+ 4 PREFERRED LTL CARRIER CHARLOTTE DISTRIBUTION CENTER 1776 Statesville Avenue YRC, ESTES, UPS Eckerd Corporation N/A 0145788920053 Charlotte, NC 28206 (704) 371-3653 DAYVILLE DISTRIBUTION CENTER Killingly Oaks Business Park YRC, ESTES, UPS, PJC Distributions Inc 500 Forbes Road N/A 0145788920054 NEW ENGLAND MOTOR Dayville, CT 06241 FREIGHT (860) 779-0632 LIVERPOOL DISTRIBUTION CENTER* YRC, ESTES, UPS, 7245 Henry Clay Boulevard Eckerd Corporation RE0356003 0145788920055 NEW ENGLAND MOTOR Liverpool, NY 13088 FREIGHT (315) 451-5700 x2274 PHILADELPHIA DISTRIBUTION CENTER YRC, ESTES, UPS, 1 Geoffrey Road Thrift Drug Inc N/A 0145788920056 NEW ENGLAND MOTOR Fairless Hills, PA 19030 FREIGHT (215) 428-5917 PERRYMAN DISTRIBUTION CENTER* YRC, ESTES, UPS, 601 Chelsea Road Rite Aid of Maryland Inc RR0236073 0145788920010 NEW ENGLAND MOTOR Aberdeen MD 21001-4306 FREIGHT (410) 297-6363 RITE AID FIXTURE DISTRIBUTION CENTER 325 Welltown Road N/A YRC, ESTES, UPS N/A 0145788920023 Winchester, VA 22603 (540) 662-3552 PONTIAC DISTRIBUTION CENTER* 5400 Perry Drive YRC, ESTES, UPS Perry Drug Stores 002230PIY 0145788920029 Waterford, MI 48329 (248) 674-7770 TUSCALOOSA DISTIBUTION CENTER* 3931 Rice Mine Road NE YRC, ESTES, UPS HARCO Inc RH0231124 0145788920035 Tuscaloosa, AL 35406 (205) 345-7419 x225 POCA DISTRIBUTION CENTER* 160 Jacobson Drive YRC, ESTES, UPS Rite Aid of West Virginia Inc 004569RDY 0145788920050 Poca WV 25159-9772 (304)
    [Show full text]
  • Leveraged Buy out of Revco D S Inc
    2012 Leveraged Buy Out of Revco D S Inc. Group - 4 Department of Finance, University of Dhaka 9/9/2012 Leverage Buyout of Revco D S Inc Submitted To: Dr. Md. Sadiqul Islam Professor Department of Finance University of Dhaka Submitted By: Group no. 4 13th batch Department of Finance University of Dhaka Date of Submission: 09 September, 2012 Group Members Name Roll Mohammed Robiul Alam 13-643 ASM Zakariya 13-578 Rokeya Mahzavin 13-588 Md. Shah Naoaj 13-686 Taslima Akter 13-666 Letter of Transmittal Dr. Md. Sadiqul Islam Professor Department of Finance University Of Dhaka Subject: Submission of Case Report. Dear Sir: With great pleasure and honor we are submitting our case report on ―Leverage Buy Out of Revco D S Inc‖. The case study includes analysis of LBO of Revco. We analyzed the LBO from different viewpoints by using various financial tools and software. We have tried our best to accommodate as much information and relevant issues as possible and follow the instructions that you have given. We would like to thank you for providing us with the opportunity to prepare this case report. Sincerely Yours Group -04 13th batch Department of Finance University of Dhaka Table of Contents 1. Introduction .................................................................................................................................................... 1 1.1. The Company ........................................................................................................................................ 1 1.2. Competition ..........................................................................................................................................
    [Show full text]
  • (NAARS): Official Listing of the Corporations Comprising the 1972 Annual Report File
    University of Mississippi eGrove American Institute of Certified Public Guides, Handbooks and Manuals Accountants (AICPA) Historical Collection 1972 National Automated Accounting Research System (NAARS): Official Listing of the Corporations Comprising the 1972 Annual Report File American Institute of Certified Public Accountants (AICPA) Follow this and additional works at: https://egrove.olemiss.edu/aicpa_guides Part of the Accounting Commons, and the Taxation Commons Recommended Citation American Institute of Certified Public Accountants (AICPA), "National Automated Accounting Research System (NAARS): Official Listing of the Corporations Comprising the 1972 Annual Report File" (1972). Guides, Handbooks and Manuals. 703. https://egrove.olemiss.edu/aicpa_guides/703 This Book is brought to you for free and open access by the American Institute of Certified Public Accountants (AICPA) Historical Collection at eGrove. It has been accepted for inclusion in Guides, Handbooks and Manuals by an authorized administrator of eGrove. For more information, please contact [email protected]. THE NATIONAL AUTOMATED ACCOUNTING RESEARCH SYSTEM NAARS OFFICIAL LISTING OF THE CORPORATIONS COMPRISING THE 1972 ANNUAL REPORT FILE PAGE 1 1972 ANNUAL REPORT FILE ALPHABETICAL LISTING COMPANY NAME SIC S EX B S DATE AUDITOR A & E PLASTIK PAK CO., INC. 309 ASE 12-31-72 PMM A.B. DICK COMPANY 508 OTC 12-31-72 AA A.E. STALEY MANUFACTURING COMPANY 204 NySE 09-30-72 HS a.g. Edwards & sons inc 621 ASE 02-28-73 TR a.h. rOBins company, incorporated 283 NYSE 12-31-72 a.m. pullen & company a.M. castle & co. 509 ASE 12-31-72 AA a.o. smith corporation 371 NYSE 12-31-72 ay a.p.s.
    [Show full text]
  • Platte City, Missouri (Kansas City MSA)
    Platte City, Missouri (Kansas City MSA) Offering Memorandum Presented by the Patton | Wiles | Fuller Group of Marcus & Millichap Platte City, Missouri (Kansas City MSA) Exclusively Listed by the Patton / Wiles / Fuller Group of Marcus & Millichap: Dustin Javitch Craig Fuller First Vice President Investments Senior Managing Director Net Leased Properties Group National Retail Group Cleveland Office Cleveland Office P: (216) 264-2025 P: (216) 264-2043 [email protected] [email protected] License: OH SAL.2012000193 License: OH SAL.2008001551 Scott Wiles Erin Patton Senior Managing Director Senior Managing Director National Retail Group National Retail Group Cleveland Office Columbus Office P: (216) 264-2026 P: (614) 360-9035 [email protected] [email protected] License: OH SAL.2005013197 License: OH SAL.2004010274 Absolute Net Lease CVS with 14.25 Years Remaining Located in the Kansas City MSA 20-MI Demographics 1301 Platte Falls Road 512,683 Platte City, MO (Kansas City MSA) 64079 Total Population Investment Highlights Location Highlights $85,217 • Absolute Net Lease CVS with 14.25 Years • Affluent Kansas City Suburb | Average Average Household Income Remaining Located in the Kansas City MSA Household Income $108,200 Within a 5-Mile Radius • 2020 Remodel to the New HealthHUB Concept | ~$450,000 in Tenant Paid • Positioned Along Area’s Major Retail & Improvements Traffic Corridor | Easy Access & Excellent Visibility 1.5% • Rare Rental Increases in Renewal Options | 15% in Option 1
    [Show full text]
  • Revised December 6, 2018
    RITE AID CORPORATION DISTRIBUTION CENTERS / SHIP–TO-LOCATIONS ENTITY REFERENCE DC SHIP-TO-LOCATIONS / PO DEA NUMBER DUNS NO.+ 4 PREFERRED LTL CARRIER LIVERPOOL DISTRIBUTION CENTER* 7245 Henry Clay Boulevard YRC, NEMF, FEDEX, ESTES, Eckerd Corporation RE0356003 0145788920055 Liverpool, NY 13088 FREIGHT, OLD DOMINION (315) 451-5700 x2274 PHILADELPHIA DISTRIBUTION CENTER 1 Geoffrey Road YRC, NEMF, FEDEX, ESTES, , Thrift Drug Inc N/A 0145788920056 Fairless Hills, PA 19030 OLD DOMINION (215) 428-5917 PERRYMAN DISTRIBUTION CENTER* 601 Chelsea Road YRC, NEMF, FEDEX, ESTES, Rite Aid of Maryland Inc RR0236073 0145788920010 Aberdeen MD 21001-4306 OLD DOMINION, SAIA (410) 297-6363 RITE AID FIXTURE DISTRIBUTION CENTER YRC, FEDEX, ESTES, 325 Welltown Road N/A N/A 0145788920023 OLD DOMINION Winchester, VA 22603 (540) 662-3552 PONTIAC DISTRIBUTION CENTER* YRC, FEDEX, ESTES, OLD 5400 Perry Drive Perry Drug Stores 002230PIY 0145788920029 DOMINION, SAIA Waterford, MI 48329 (248) 674-7770 ICE CREAM DIVISION YRC, FEDEX, ESTES, OLD 9200 Telstar Avenue ---------------------- N/A 0145788920061 DOMINION, SAIA El Monte, CA 91731 (626) 571-0122 WILSONVILLE DISTRIBUTION CENTER YRC, FEDEX, ESTES, OLD 29555 SW Boones Ferry Road Thrifty Payless Inc N/A 0145788920080 DOMINION, SAIA Wilsonville, OR 97070 (503) 685-6013 WOODLAND DISTRIBUTION CENTER* 1755 East Beamer Street YRC, FEDEX, ESTES, OLD Thrifty Payless INC RT0223874 0145788920081 Woodland, CA 95776 DOMINION, SAIA (530) 661-1800 x124 LANCASTER DISTRIBUTION CENTER YRC, FEDEX, ESTES, OLD 2801 West Avenue H Thrifty Payless INC N/A 0145788920088 DOMINION, SAIA Lancaster, CA 93536 (661) 951-7565 Contact the Rite Aid Transportation Department with any questions regarding Rite Aid Preferred Carriers and inbound routing prior to shipping.
    [Show full text]